Hesai Group reported a 13.5% year-on-year increase in adjusted net profit for the third quarter of 2026, driven by a 67.6% rise in ADAS lidar shipments and a strong gross margin of 41%. The company is successfully diversifying its business away from the struggling Chinese automotive market, with robotics-related segments now contributing over half of group sales. Strategic Growth Initiatives are expected to boost revenues further in fiscal year 2027, supporting a positive outlook and maintaining Hesai's 'Buy' rating.
Hesai Group's adjusted net profit rose 13.5% year-on-year in Q3 2026, supported by a 67.6% increase in ADAS lidar shipments and a 41% gross margin. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 12, 2026 22:11 WIB: out of 150 priced US tech stocks, 32 rose and 117 fell. Notable movers include Aehr Test Systems at USD 60.67 with a 7.77% decline and HubSpot Inc at USD 217.45 with a 7.18% gain, while Strategy Inc. traded at USD 113.57 down 7.18%.
D.A. Davidson raised Riskified's price target to $12, reflecting a 22.2% potential upside from $9.82. The company reported a 41% revenue increase to $115.2 million and adjusted earnings of $0.07 per share, beating estimates. Profitability improved wi...
TRM Labs introduced the Disruption Awards to recognize coalitions of public and private organizations that successfully disrupted major cybercrimes in 2026. Winners include groups that took down a phishing service responsible for most Microsoft-block...
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
